12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
During Wednesday's pre-market session, several healthcare stocks experienced significant movements. Impel Pharmaceuticals, C4 Therapeutics, RVL Pharmaceuticals, Plus Therapeutics, GRI Bio, and MAIA Biotechnology saw increases in their share prices. Conversely, Amneal Pharmaceuticals, IMAC Hldgs, Bluejay Diagnostics, Comera Life Sciences, Nymox Pharmaceutical, and Macrogenics experienced decreases.
July 05, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
C4 Therapeutics shares rose 19.08% during Wednesday's pre-market session.
The significant increase in C4 Therapeutics' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
GRI Bio shares increased by 11.26% during Wednesday's pre-market session.
The significant increase in GRI Bio's share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Impel Pharmaceuticals shares rose 34.7% during Wednesday's pre-market session.
The significant increase in Impel Pharmaceuticals' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
MAIA Biotechnology shares increased by 8.75% during Wednesday's pre-market session.
The significant increase in MAIA Biotechnology's share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Plus Therapeutics stock moved upwards by 13.08% during Wednesday's pre-market session.
The significant increase in Plus Therapeutics' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
RVL Pharmaceuticals stock rose 15.34% during Wednesday's pre-market session.
The significant increase in RVL Pharmaceuticals' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Amneal Pharmaceuticals shares fell 15.7% during Wednesday's pre-market session.
The significant decrease in Amneal Pharmaceuticals' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
IMAC Hldgs stock fell 14.75% during Wednesday's pre-market session.
The significant decrease in IMAC Hldgs' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Bluejay Diagnostics shares fell 11.12% during Wednesday's pre-market session.
The significant decrease in Bluejay Diagnostics' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Comera Life Sciences shares decreased by 9.62% during Wednesday's pre-market session.
The significant decrease in Comera Life Sciences' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Macrogenics shares decreased by 7.11% during Wednesday's pre-market session.
The significant decrease in Macrogenics' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Nymox Pharmaceutical shares declined by 7.26% during Wednesday's pre-market session.
The significant decrease in Nymox Pharmaceutical's share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100